Cargando…

Pharmacodynamic Evaluation of Zoliflodacin Treatment of Neisseria gonorrhoeae Strains With Amino Acid Substitutions in the Zoliflodacin Target GyrB Using a Dynamic Hollow Fiber Infection Model

Novel antimicrobials for effective treatment of uncomplicated gonorrhea are essential, and the first-in-class, oral spiropyrimidinetrione DNA gyrase B inhibitor zoliflodacin appears promising. Using our newly developed Hollow Fiber Infection Model (HFIM), the pharmacodynamics of zoliflodacin was exa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jacobsson, Susanne, Golparian, Daniel, Oxelbark, Joakim, Franceschi, Francois, Brown, David, Louie, Arnold, Drusano, George, Unemo, Magnus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046595/ https://www.ncbi.nlm.nih.gov/pubmed/35496288 http://dx.doi.org/10.3389/fphar.2022.874176

Ejemplares similares

Pharmacodynamic Evaluation of Dosing, Bacterial Kill, and Resistance Suppression for Zoliflodacin Against Neisseria gonorrhoeae in a Dynamic Hollow Fiber Infection Model
por: Jacobsson, Susanne, et al.
Publicado: (2021)

Complete Reference Genome Sequence of the Clinical Neisseria gonorrhoeae Strain H035, with Resistance to the Novel Antimicrobial Zoliflodacin, Identified in Japan in 2000
por: Golparian, Daniel, et al.
Publicado: (2023)

Pharmacodynamic evaluation of lefamulin in the treatment of gonorrhea using a hollow fiber infection model simulating Neisseria gonorrhoeae infections
por: Jacobsson, Susanne, et al.
Publicado: (2022)

Susceptibility Trends of Zoliflodacin against Multidrug-Resistant Neisseria gonorrhoeae Clinical Isolates in Nanjing, China, 2014 to 2018
por: Le, Wenjing, et al.
Publicado: (2021)

Neisseria gonorrhoeae diagnostic escape from a gyrA-based test for ciprofloxacin susceptibility and the effect on zoliflodacin resistance: a bacterial genetics and experimental evolution study
por: Rubin, Daniel H F, et al.
Publicado: (2023)

Now Is the Time to Implement Whole Genome Sequencing in the Global Antimicrobial Resistance Surveillance for Neisseria gonorrhoeae?
por: Golparian, Daniel, et al.
Publicado: (2019)

A 2.8 Å Structure of Zoliflodacin in a DNA Cleavage Complex with Staphylococcus aureus DNA Gyrase
por: Morgan, Harry, et al.
Publicado: (2023)

Antimicrobial resistance in Neisseria gonorrhoeae isolates and gonorrhoea treatment in the Republic of Belarus, Eastern Europe, 2009–2019
por: Aniskevich, Aliaksandra, et al.
Publicado: (2021)

Extensively drug-resistant (XDR) Neisseria gonorrhoeae causing possible gonorrhoea treatment failure with ceftriaxone plus azithromycin in Austria, April 2022
por: Pleininger, Sonja, et al.
Publicado: (2022)

Genetic Resistance Determinants, In Vitro Time-Kill Curve Analysis and Pharmacodynamic Functions for the Novel Topoisomerase II Inhibitor ETX0914 (AZD0914) in Neisseria gonorrhoeae
por: Foerster, Sunniva, et al.
Publicado: (2015)

A Novel Oral GyrB/ParE Dual Binding Inhibitor Effective against Multidrug-Resistant Neisseria gonorrhoeae and Other High-Threat Pathogens
por: Park, Steven, et al.
Publicado: (2022)

Genetic variation regulates the activation and specificity of Restriction-Modification systems in Neisseria gonorrhoeae
por: Sánchez-Busó, Leonor, et al.
Publicado: (2019)

Effect of food on the pharmacokinetics of zoliflodacin granules for oral suspension: Phase I open‐label randomized cross‐over study in healthy subjects
por: Luckey, Alison, et al.
Publicado: (2023)

Identification of the likely translational start of Mycobacterium tuberculosis GyrB
por: Karkare, Shantanu, et al.
Publicado: (2013)

Antimicrobial resistance and molecular epidemiological typing of Neisseria gonorrhoeae isolates from Kyrgyzstan in Central Asia, 2012 and 2017
por: Karymbaeva, Saliya, et al.
Publicado: (2021)

Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from Vietnam, 2011
por: Olsen, Birgitta, et al.
Publicado: (2013)

Complete Reference Genome Sequence of the Extensively Drug-Resistant Strain Neisseria gonorrhoeae AT159, with Ceftriaxone Resistance and High-Level Azithromycin Resistance, Using Nanopore Q20+ Chemistry and Illumina Sequencing
por: Golparian, Daniel, et al.
Publicado: (2022)

Genomic Epidemiology of Azithromycin-Nonsusceptible Neisseria gonorrhoeae, Argentina, 2005–2019
por: Gianecini, Ricardo Ariel, et al.
Publicado: (2021)

Current and future antimicrobial treatment of gonorrhoea – the rapidly evolving Neisseria gonorrhoeae continues to challenge
por: Unemo, Magnus
Publicado: (2015)

Time-kill curve analysis and pharmacodynamic modelling for in vitro evaluation of antimicrobials against Neisseria gonorrhoeae
por: Foerster, Sunniva, et al.
Publicado: (2016)

New Insights into Fluoroquinolone Resistance in Mycobacterium tuberculosis: Functional Genetic Analysis of gyrA and gyrB Mutations
por: Malik, Seidu, et al.
Publicado: (2012)

Alterations of gyrA, gyrB, and parC and Activity of Efflux Pump in Fluoroquinolone-resistant Acinetobacter baumannii
por: Park, Sunok, et al.
Publicado: (2011)

Genomic analysis and antimicrobial resistance of Neisseria gonorrhoeae isolates from Vietnam in 2011 and 2015–16
por: Lan, Pham Thi, et al.
Publicado: (2020)

Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from India, Pakistan and Bhutan in 2007–2011
por: Sethi, Sunil, et al.
Publicado: (2013)

Mutations in gyrB play an important role in ciprofloxacin-resistant Pseudomonas aeruginosa
por: Feng, Xinyuan, et al.
Publicado: (2019)

Fluoroquinolone Resistance Linked to GyrA, GyrB, and ParC Mutations in Salmonella enterica Typhimurium Isolates in Humans
por: Casin, Isabelle, et al.
Publicado: (2003)

First National Genomic Epidemiological Study of Neisseria gonorrhoeae Strains Spreading Across Sweden in 2016
por: Hadad, Ronza, et al.
Publicado: (2022)

Antimicrobial resistance prediction and phylogenetic analysis of Neisseria gonorrhoeae isolates using the Oxford Nanopore MinION sequencer
por: Golparian, Daniel, et al.
Publicado: (2018)

Will Genome Analysis Elucidate Evolution, Global Transmission and Virulence of Neisseria Meningitidis Lineages?
por: Golparian, Daniel, et al.
Publicado: (2015)

Antimicrobial resistance and Neisseria gonorrhoeae multiantigen sequence typing (NG-MAST) genotypes in N. gonorrhoeae during 2012–2014 in Karachi, Pakistan
por: Jabeen, Kauser, et al.
Publicado: (2016)

In vitro activity of the novel oral antimicrobial SMT-571, with a new mechanism of action, against MDR and XDR Neisseria gonorrhoeae: future treatment option for gonorrhoea?
por: Jacobsson, Susanne, et al.
Publicado: (2019)

Antimicrobial susceptibility/resistance and NG-MAST characterisation of Neisseria gonorrhoeae in Belarus, Eastern Europe, 2010–2013
por: Lebedzeu, Fiodar, et al.
Publicado: (2015)

Antimicrobial susceptibility/resistance and genetic characteristics of Neisseria gonorrhoeae isolates from Poland, 2010-2012
por: Mlynarczyk-Bonikowska, Beata, et al.
Publicado: (2014)

First antimicrobial resistance data and genetic characteristics of Neisseria gonorrhoeae isolates from Estonia, 2009–2013
por: Golparian, D, et al.
Publicado: (2014)

A Single Amino Acid Substitution in Elongation Factor G Can Confer Low-Level Gentamicin Resistance in Neisseria gonorrhoeae
por: Holley, Concerta L., et al.
Publicado: (2022)

A novel gyrB gene mutation in fluoroquinolone resistant clinical isolates of Mycobacterium tuberculosis
por: Singh, Pooja, et al.
Publicado: (2014)

Frequency and Geographic Distribution of gyrA and gyrB Mutations Associated with Fluoroquinolone Resistance in Clinical Mycobacterium Tuberculosis Isolates: A Systematic Review
por: Avalos, Elisea, et al.
Publicado: (2015)

gyrA and parC mutations in fluoroquinolone-resistant Neisseria gonorrhoeae isolates from Kenya
por: Kivata, Mary Wandia, et al.
Publicado: (2019)

Multidrug-resistant Neisseria gonorrhoeae isolate SE690: mosaic penA-60.001 gene causing ceftriaxone resistance internationally has spread to the more antimicrobial-susceptible genomic lineage, Sweden, September 2022
por: Golparian, Daniel, et al.
Publicado: (2023)

Fitness cost and benefit of antimicrobial resistance in Neisseria gonorrhoeae: Multidisciplinary approaches are needed
por: Unemo, Magnus, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_rb7e122satpgqs44ko352ql9u9